Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors.

A review of studies found fear of cancer recurrence among AYA survivors is prevalent, but research on interventions specific to this age group is limited.

Pediatric cancer patients and their caregivers largely prefer to access test results immediately through the patient portal rather than wait to hear about results from oncologists, according to survey ...

Young adults caring for parents with cancer at end-of-life need age-tailored and resiliency-focused support strategies.

Some patients with locally advanced esophageal cancer may be able to safely forgo esophagectomy after CRT, data suggest.

Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea.

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

Study authors examined the diagnostic utility of radiologic imaging for patients with high-risk cutaneous squamous cell carcinoma.

The CISTO study is the only going prospective study comparing radical cystectomy vs bladder-sparing options for high-grade NMIBC.

Researchers sought to determine whether venetoclax plus low-intensity chemotherapy would be effective in adult patients with ALL.

Overall survival after HCT for high-risk features in patients with SDS was superior to OS for HCT for MDS/AML, particularly ...

Although there has been steady uptake of targeted therapies across LOTs, unmet need persists for patients with CLL/SLL who receive later LOTs. The time to the next treatment decreased with each LOT, ...